Join the EpiPen group to help and get support from people like you.
EpiPen News
AAAAI: Nasal Delivery of Epinephrine Safe, Effective for Anaphylaxis
WEDNESDAY, March 6, 2024 – Nasal powder formulations of epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the American Academy...
AAAAI: Nasal Delivery of Epinephrine Safe, Effective for Anaphylaxis
WEDNESDAY, March 6, 2024 – Nasal powder formulations of epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the American Academy...
Allergy Alert: What Could New Guidelines on Anaphylaxis Mean for You?
TUESDAY, Jan. 23, 2024 – If you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis,...
FDA Wants More Data on Neffy, First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 – In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe...
FDA Medwatch Alert: Spectrum Laboratory Products, Inc. Issues Voluntary Worldwide Recall of Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API) Due to Discoloration of Product
January 9, 2023 – Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API) used to manufacture or...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals of EpiPen Auto-Injector Errors Related to Device Malfunctions and User Administration
March 24, 2020 – FDA is alerting patients, caregivers and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may potentially have...
FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube
[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEP...
FDA Medwatch Alert: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
ISSUE: Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (...
Further information
Related condition support groups
Anaphylaxis, Allergic Reactions